Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal size of the clitoris (HP:0040252)help
Parent Node:
expand
Increased size of the clitoris (HP:0040253)help
..Starting node
..expand
Clitoral hypertrophy (HP:0008665)help
Term ID: 8665
Name: Clitoral hypertrophy
Synonym: Clitoral enlargement; Clitoromegaly; Enlarged clitoris; Hypertrophic clitoris; Prominent clitoris
Definition: Hypertrophy of the clitoris.
Comments:
Reference: HP:0008665
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0008665HP:0008665Clitoral hypertrophy0AGPAT2 CL E G H10555325ORPHA:528Congenital generalized lipodystrophyHP:0040283 - Occasional85
HP:0008665HP:0008665Clitoral hypertrophy0AGPAT2 CL E G H10555325OMIM:608594Lipodystrophy, congenital generalized, type 1.85
HP:0008665HP:0008665Clitoral hypertrophy0AR CL E G H367644ORPHA:90797Partial androgen insensitivity syndromeHP:0040283 - Occasional125
HP:0008665HP:0008665Clitoral hypertrophy0ARID1B CL E G H5749218040OMIM:135900Coffin-Siris syndrome 1219
HP:0008665HP:0008665Clitoral hypertrophy0ATIC CL E G H471794ORPHA:250977AICA-ribosiduriaHP:0040281 - Very frequent4
HP:0008665HP:0008665Clitoral hypertrophy0ATIC CL E G H471794OMIM:608688Aicar transformylase/imp cyclohydrolase deficiency.4
HP:0008665HP:0008665Clitoral hypertrophy0ATR CL E G H545882OMIM:210600Seckel syndrome 1.168
HP:0008665HP:0008665Clitoral hypertrophy0BSCL2 CL E G H2658015832ORPHA:528Congenital generalized lipodystrophyHP:0040283 - Occasional105
HP:0008665HP:0008665Clitoral hypertrophy0BSCL2 CL E G H2658015832OMIM:269700Lipodystrophy, congenital generalized, type 2.105
HP:0008665HP:0008665Clitoral hypertrophy0CAV1 CL E G H8571527ORPHA:528Congenital generalized lipodystrophyHP:0040283 - Occasional11
HP:0008665HP:0008665Clitoral hypertrophy0CAVIN1 CL E G H2841199688ORPHA:528Congenital generalized lipodystrophyHP:0040283 - Occasional48
HP:0008665HP:0008665Clitoral hypertrophy0CCNQ CL E G H9200228434ORPHA:140952Syndactyly-telecanthus-anogenital and renal malformations syndromeHP:0040282 - Frequent7
HP:0008665HP:0008665Clitoral hypertrophy0CCNQ CL E G H9200228434OMIM:300707Toe syndactyly, telecanthus, and anogenital and renal malformations.7
HP:0008665HP:0008665Clitoral hypertrophy0CD96 CL E G H1022516892OMIM:211750C syndrome.83
HP:0008665HP:0008665Clitoral hypertrophy0CDC45 CL E G H83181739ORPHA:2554Ear-patella-short stature syndromeHP:0040282 - Frequent9
HP:0008665HP:0008665Clitoral hypertrophy0CDC45 CL E G H83181739OMIM:617063Meier-Gorlin syndrome 7.9
HP:0008665HP:0008665Clitoral hypertrophy0CDC6 CL E G H9901744ORPHA:2554Ear-patella-short stature syndromeHP:0040282 - Frequent31
HP:0008665HP:0008665Clitoral hypertrophy0CDT1 CL E G H8162024576ORPHA:2554Ear-patella-short stature syndromeHP:0040282 - Frequent50
HP:0008665HP:0008665Clitoral hypertrophy0CEP152 CL E G H2299529298OMIM:613823Seckel syndrome 5HP:0040283 - Occasional146
HP:0008665HP:0008665Clitoral hypertrophy0COX7B CL E G H13492291ORPHA:2556Microphthalmia with linear skin defects syndromeHP:0040283 - Occasional6
HP:0008665HP:0008665Clitoral hypertrophy0COX7B CL E G H13492291OMIM:309801Microphthalmia, syndromic 7.6
HP:0008665HP:0008665Clitoral hypertrophy0CYP11A1 CL E G H15832590ORPHA:16855846,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiencyHP:0040283 - Occasional31
HP:0008665HP:0008665Clitoral hypertrophy0CYP11A1 CL E G H15832590ORPHA:289548Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiencyHP:0040283 - Occasional31
HP:0008665HP:0008665Clitoral hypertrophy0CYP11B1 CL E G H15842591OMIM:202010Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency.112
HP:0008665HP:0008665Clitoral hypertrophy0CYP11B1 CL E G H15842591ORPHA:90795Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiencyHP:0040282 - Frequent112
HP:0008665HP:0008665Clitoral hypertrophy0DHCR7 CL E G H17172860ORPHA:818Smith-Lemli-Opitz syndromeHP:0040282 - Frequent159
HP:0008665HP:0008665Clitoral hypertrophy0DHX37 CL E G H5764717210ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent2
HP:0008665HP:0008665Clitoral hypertrophy0DMRT3 CL E G H5852413909ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent1
HP:0008665HP:0008665Clitoral hypertrophy0ESCO2 CL E G H15757027230OMIM:268300Roberts syndrome.92
HP:0008665HP:0008665Clitoral hypertrophy0ESCO2 CL E G H15757027230ORPHA:3103Roberts syndromeHP:0040282 - Frequent92
HP:0008665HP:0008665Clitoral hypertrophy0FDXR CL E G H22323642ORPHA:543470Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndromeHP:0040283 - Occasional
HP:0008665HP:0008665Clitoral hypertrophy0FGFR2 CL E G H22633689OMIM:614592Bent bone dysplasia syndrome.175
HP:0008665HP:0008665Clitoral hypertrophy0FGFR2 CL E G H22633689ORPHA:313855FGFR2-related bent bone dysplasiaHP:0040281 - Very frequent175
HP:0008665HP:0008665Clitoral hypertrophy0FIG4 CL E G H989616873ORPHA:3472Yunis-Varon syndromeHP:0040283 - Occasional111
HP:0008665HP:0008665Clitoral hypertrophy0FOS CL E G H23533796ORPHA:528Congenital generalized lipodystrophyHP:0040283 - Occasional
HP:0008665HP:0008665Clitoral hypertrophy0FRAS1 CL E G H8014419185OMIM:219000Fraser syndrome.353
HP:0008665HP:0008665Clitoral hypertrophy0GAD1 CL E G H25714092OMIM:619124DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 89; DEE8944
HP:0008665HP:0008665Clitoral hypertrophy0GATA4 CL E G H26264173ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent87
HP:0008665HP:0008665Clitoral hypertrophy0GMNN CL E G H5105317493ORPHA:2554Ear-patella-short stature syndromeHP:0040282 - Frequent3
HP:0008665HP:0008665Clitoral hypertrophy0HCCS CL E G H30524837ORPHA:2556Microphthalmia with linear skin defects syndromeHP:0040283 - Occasional11
HP:0008665HP:0008665Clitoral hypertrophy0HCCS CL E G H30524837OMIM:309801Microphthalmia, syndromic 7.11
HP:0008665HP:0008665Clitoral hypertrophy0HSD3B2 CL E G H32845218ORPHA:90791Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiencyHP:0040282 - Frequent34
HP:0008665HP:0008665Clitoral hypertrophy0INSR CL E G H36436091OMIM:246200Donohue syndrome.229
HP:0008665HP:0008665Clitoral hypertrophy0INSR CL E G H36436091ORPHA:508LeprechaunismHP:0040282 - Frequent229
HP:0008665HP:0008665Clitoral hypertrophy0INSR CL E G H36436091OMIM:262190Pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities.229
HP:0008665HP:0008665Clitoral hypertrophy0INSR CL E G H36436091ORPHA:769Rabson-Mendenhall syndromeHP:0040282 - Frequent229
HP:0008665HP:0008665Clitoral hypertrophy0KAT6B CL E G H2352217582OMIM:606170Genitopatellar syndrome.141
HP:0008665HP:0008665Clitoral hypertrophy0KAT6B CL E G H2352217582ORPHA:85201Genitopatellar syndromeHP:0040281 - Very frequent141
HP:0008665HP:0008665Clitoral hypertrophy0MAP3K1 CL E G H42146848ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent13
HP:0008665HP:0008665Clitoral hypertrophy0MAP3K1 CL E G H42146848OMIM:61376246,xy sex reversal 6HP:0040283 - Occasional13
HP:0008665HP:0008665Clitoral hypertrophy0MINPP1 CL E G H95627102ORPHA:284339Pontocerebellar hypoplasia type 7HP:0040283 - Occasional3
HP:0008665HP:0008665Clitoral hypertrophy0NDUFB11 CL E G H5453920372ORPHA:2556Microphthalmia with linear skin defects syndromeHP:0040283 - Occasional3
HP:0008665HP:0008665Clitoral hypertrophy0NDUFB11 CL E G H5453920372OMIM:309801Microphthalmia, syndromic 7.3
HP:0008665HP:0008665Clitoral hypertrophy0NR0B1 CL E G H1907960ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent48
HP:0008665HP:0008665Clitoral hypertrophy0NR5A1 CL E G H25167983OMIM:61748046,xx sex reversal 4.38
HP:0008665HP:0008665Clitoral hypertrophy0NR5A1 CL E G H25167983ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent38
HP:0008665HP:0008665Clitoral hypertrophy0NR5A1 CL E G H25167983OMIM:61296546XY sex reversal 338
HP:0008665HP:0008665Clitoral hypertrophy0NR5A1 CL E G H25167983OMIM:612964PREMATURE OVARIAN FAILURE 7; POF738
HP:0008665HP:0008665Clitoral hypertrophy0ORC1 CL E G H49988487ORPHA:2554Ear-patella-short stature syndromeHP:0040282 - Frequent53
HP:0008665HP:0008665Clitoral hypertrophy0ORC1 CL E G H49988487OMIM:224690Meier-Gorlin syndrome 1.53
HP:0008665HP:0008665Clitoral hypertrophy0ORC4 CL E G H50008490ORPHA:2554Ear-patella-short stature syndromeHP:0040282 - Frequent21
HP:0008665HP:0008665Clitoral hypertrophy0ORC4 CL E G H50008490OMIM:613800Meier-Gorlin syndrome 2.21
HP:0008665HP:0008665Clitoral hypertrophy0ORC6 CL E G H2359417151ORPHA:2554Ear-patella-short stature syndromeHP:0040282 - Frequent39
HP:0008665HP:0008665Clitoral hypertrophy0ORC6 CL E G H2359417151OMIM:613803Meier-Gorlin syndrome 3.39
HP:0008665HP:0008665Clitoral hypertrophy0PEX1 CL E G H51898850OMIM:214100Peroxisome biogenesis disorder 1A (Zellweger).169
HP:0008665HP:0008665Clitoral hypertrophy0PEX1 CL E G H51898850ORPHA:912Zellweger syndromeHP:0040282 - Frequent169
HP:0008665HP:0008665Clitoral hypertrophy0PEX10 CL E G H51928851ORPHA:912Zellweger syndromeHP:0040282 - Frequent75
HP:0008665HP:0008665Clitoral hypertrophy0PEX11B CL E G H87998853ORPHA:912Zellweger syndromeHP:0040282 - Frequent4
HP:0008665HP:0008665Clitoral hypertrophy0PEX12 CL E G H51938854ORPHA:912Zellweger syndromeHP:0040282 - Frequent65
HP:0008665HP:0008665Clitoral hypertrophy0PEX13 CL E G H51948855ORPHA:912Zellweger syndromeHP:0040282 - Frequent66
HP:0008665HP:0008665Clitoral hypertrophy0PEX14 CL E G H51958856ORPHA:912Zellweger syndromeHP:0040282 - Frequent46
HP:0008665HP:0008665Clitoral hypertrophy0PEX16 CL E G H94098857ORPHA:912Zellweger syndromeHP:0040282 - Frequent59
HP:0008665HP:0008665Clitoral hypertrophy0PEX19 CL E G H58249713ORPHA:912Zellweger syndromeHP:0040282 - Frequent62
HP:0008665HP:0008665Clitoral hypertrophy0PEX2 CL E G H58289717OMIM:614866Peroxisome biogenesis disorder 5A (Zellweger).82
HP:0008665HP:0008665Clitoral hypertrophy0PEX2 CL E G H58289717ORPHA:912Zellweger syndromeHP:0040282 - Frequent82
HP:0008665HP:0008665Clitoral hypertrophy0PEX26 CL E G H5567022965ORPHA:912Zellweger syndromeHP:0040282 - Frequent106
HP:0008665HP:0008665Clitoral hypertrophy0PEX3 CL E G H85048858ORPHA:912Zellweger syndromeHP:0040282 - Frequent47
HP:0008665HP:0008665Clitoral hypertrophy0PEX5 CL E G H58309719OMIM:214110Peroxisome biogenesis disorder 2A (Zellweger).99
HP:0008665HP:0008665Clitoral hypertrophy0PEX5 CL E G H58309719ORPHA:912Zellweger syndromeHP:0040282 - Frequent99
HP:0008665HP:0008665Clitoral hypertrophy0PEX6 CL E G H51908859ORPHA:912Zellweger syndromeHP:0040282 - Frequent98
HP:0008665HP:0008665Clitoral hypertrophy0POR CL E G H54479208OMIM:201750Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis.76
HP:0008665HP:0008665Clitoral hypertrophy0PPARG CL E G H54689236ORPHA:528Congenital generalized lipodystrophyHP:0040283 - Occasional42
HP:0008665HP:0008665Clitoral hypertrophy0PPP1R12A CL E G H46597618OMIM:618820GENITOURINARY AND/OR BRAIN MALFORMATION SYNDROME; GUBS
HP:0008665HP:0008665Clitoral hypertrophy0RSPO1 CL E G H28465421679OMIM:610644Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and 46,xx sex reversal.3
HP:0008665HP:0008665Clitoral hypertrophy0SOX9 CL E G H666211204ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent109
HP:0008665HP:0008665Clitoral hypertrophy0SRY CL E G H673611311ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent23
HP:0008665HP:0008665Clitoral hypertrophy0SRY CL E G H673611311OMIM:40004546XX sex reversal 1.23
HP:0008665HP:0008665Clitoral hypertrophy0TALDO1 CL E G H688811559OMIM:606003Transaldolase deficiency34
HP:0008665HP:0008665Clitoral hypertrophy0TOE1 CL E G H11403415954ORPHA:284339Pontocerebellar hypoplasia type 7HP:0040283 - Occasional6
HP:0008665HP:0008665Clitoral hypertrophy0TRAIP CL E G H1029330764OMIM:616777Seckel syndrome 9.2
HP:0008665HP:0008665Clitoral hypertrophy0UBE3B CL E G H8991013478OMIM:244450Kaufman oculocerebrofacial syndrome.13
HP:0008665HP:0008665Clitoral hypertrophy0UBE3B CL E G H8991013478ORPHA:2707Oculocerebrofacial syndrome, Kaufman typeHP:0040283 - Occasional13
HP:0008665HP:0008665Clitoral hypertrophy0UBR1 CL E G H19713116808OMIM:243800Johanson-Blizzard syndrome.25
HP:0008665HP:0008665Clitoral hypertrophy0VAC14 CL E G H5569725507ORPHA:3472Yunis-Varon syndromeHP:0040283 - Occasional6
HP:0008665HP:0008665Clitoral hypertrophy0VAMP7 CL E G H684511486ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent2
HP:0008665HP:0008665Clitoral hypertrophy0WT1 CL E G H749012796ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent177
HP:0008665HP:0008665Clitoral hypertrophy0WWOX CL E G H5174112799ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent149
HP:0008665HP:0008665Clitoral hypertrophy0ZFPM2 CL E G H2341416700ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent31


Genes (70) :AGPAT2 AR ARID1B ATIC ATR BSCL2 CAV1 CAVIN1 CCNQ CD96 CDC45 CDC6 CDT1 CEP152 COX7B CYP11A1 CYP11B1 DHCR7 DHX37 DMRT3 ESCO2 FDXR FGFR2 FIG4 FOS FRAS1 GAD1 GATA4 GMNN HCCS HSD3B2 INSR KAT6B MAP3K1 MINPP1 NDUFB11 NR0B1 NR5A1 ORC1 ORC4 ORC6 PEX1 PEX10 PEX11B PEX12 PEX13 PEX14 PEX16 PEX19 PEX2 PEX26 PEX3 PEX5 PEX6 POR PPARG PPP1R12A RSPO1 SOX9 SRY TALDO1 TOE1 TRAIP UBE3B UBR1 VAC14 VAMP7 WT1 WWOX ZFPM2

Diseases (58) :ORPHA:528 OMIM:608594 ORPHA:90797 OMIM:135900 ORPHA:250977 OMIM:608688 OMIM:210600 OMIM:269700 ORPHA:140952 OMIM:300707 OMIM:211750 ORPHA:2554 OMIM:617063 OMIM:613823 ORPHA:2556 OMIM:309801 ORPHA:168558 ORPHA:289548 OMIM:202010 ORPHA:90795 ORPHA:818 ORPHA:251510 OMIM:268300 ORPHA:3103 ORPHA:543470 OMIM:614592 ORPHA:313855 ORPHA:3472 OMIM:219000 OMIM:619124 ORPHA:90791 OMIM:246200 ORPHA:508 OMIM:262190 ORPHA:769 OMIM:606170 ORPHA:85201 OMIM:613762 ORPHA:284339 OMIM:617480 OMIM:612965 OMIM:612964 OMIM:224690 OMIM:613800 OMIM:613803 OMIM:214100 ORPHA:912 OMIM:614866 OMIM:214110 OMIM:201750 OMIM:618820 OMIM:610644 OMIM:400045 OMIM:606003 OMIM:616777 OMIM:244450 ORPHA:2707 OMIM:243800
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.